26.07.2012 • NewsExxonMobilQ2 2012oil industry

ExxonMobil Profit Lower than Expexted

ExxonMobil, the world's largest publicly traded oil company, posted lower-than-expected quarterly earnings on Thursday as its oil and gas output sagged and its chemicals business struggled.

Weaker global oil prices have weighed on earnings across the sector, and Exxon also felt the sting of decade-low U.S. natural gas prices.

The company, which has pledged to spend a record $37 billion this year as it brings new projects on line, said oil and gas output fell 5.6% to 4.15 million barrels oil equivalent per day during the quarter.

"Production was a little light," Pavel Molchanov, analyst at Raymond James, said. "The real swing versus our estimates was chemicals."

The Irving, Texas, company reported a second-quarter profit of $15.9 billion, or $3.41 per share, up from $10.68 billion, or $2.18 per share, a year earlier.

Profit was boosted by a $7.5 billion gain related to the sale of a stake in its Japanese refining and chemicals business, and tax items.

Excluding those one-time gains, Exxon earned $8.4 billion, or $1.80 per share. On that basis, analysts' average forecast was $1.95, according to Thomson Reuters I/B/E/S.

Excluding one-time items, earnings from the company's chemical operations totaled $820 million, nearly 33% below Raymond James' estimate for the unit, Molchanov said.

Weakness in the chemicals market was also evident in the earnings of Dow Chemical, which reported a 34% drop in quarterly profit, missing Wall Street forecasts.

Earlier on Thursday, Royal Dutch Shell posted lower-than-expected quarterly earnings of $5.7 billion, hurt by maintenance costs and shutdowns in the U.S. Gulf, where the company has some of its most profitable production, and in Australian Liquefied Natural Gas.

Exxon's earnings from U.S. oil and gas production tumbled by more than half in the second quarter to $678 million, largely due to the steep decline in prices of natural gas.

The company is the nation's largest producer of natural gas, but Chief Executive Officer Rex Tillerson warned last month that prices were too low to allow the industry to cover the cost of finding and producing new supply.

"We are all losing our shirts today," Tillerson said at the time.

 

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.